Axoltis’ Phase II ALS trial fails; company points to exploratory endpoints
Axoltis Pharma is undertaking additional analysis of its Phase II amyotrophic lateral sclerosis (ALS) trial after it failed to meet…
Central Nervous System
-
-
AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win
AbbVie’s preventative migraine therapy, Qulipta (atogepant), has netted a successful late-stage readout in menstrual migraine, potentially poising the drug for…
-
Biohaven’s epilepsy drug hit with FDA clinical hold
The US Food and Drug Administration (FDA) has placed a partial clinical hold on the pivotal trials evaluating Biohaven’s epilepsy…
-
Can CNS trial momentum convert into late-stage evidence?
The central nervous system (CNS) remains one of biopharma’s most strategically important therapy areas in 2026, but GlobalData’s clinical trials…
-
Narcolepsy market expected to reach $7.8bn across 7MM by 2035
The narcolepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is…
-
Podcast: Bringing diversity to Alzheimer’s trials
In recent years, the Alzheimer’s disease market has seen several developments, including the debut of the first disease-modifying therapies (DMTs),…
-
BioVie stock sinks on Phase IIb Parkinson’s trial data
BioVie’s stock crashed after the biotech released data from its Phase IIb Parkinson’s disease trial that used a unique composite…
-
Schizophrenia “non-responders” may need more time, study finds
A research study has indicated that researchers should better consider time differences between individual symptom improvement during schizophrenia clinical trials.…
-
MapLight Therapeutics stock crashes on Phase II schizophrenia data
MapLight Therapeutics’ stock crashed by more than 70% after the release of data from its Phase II schizophrenia trial, despite…
-
Loneliness interventions do not have strong sustained effects on memory function
Loneliness, defined as a subjective experience of a discrepancy between the preferred interpersonal relationship an individual has and their actual…
